SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control von Cowie, Martin R., Fisher, Miles

Volltext

Traumatic Transradial Forearm Amputation Temporized With Extracorporeal Membrane Oxygenation: A Brief Report von Hegeman, Erik M, Fisher, Miles W A, Cognetti, Daniel J, Plucknette, Benjamin F, Alderete, Joseph F, Wilson, David, Causey, Marlin Wayne

Volltext

Zone 2 Flexor Tendon Repair Location and Risk of Catching on the A2 Pulley von Altman, Perry R., Fisher, Miles W.A., Goyal, Kanu S.

Volltext

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a... von Heller, Simon, Prof, Buse, John, Prof, Fisher, Miles, Prof, Garg, Satish, Prof, Marre, Michel, Prof, Merker, Ludwig, MD, Renard, Eric, Prof, Russell-Jones, David, Prof, Philotheou, Areti, MBChB, Francisco, Ann Marie Ocampo, MD, Pei, Huiling, PhD, Bode, Bruce, MD

Volltext

Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma von Hering, Kalei, Fisher, Miles W.A., Dalton, Michael K., Simpson, Andrew K., Ye, Jamie, Suneja, Nishant, Cooper, Zara, Koehlmoos, Tracey P., Schoenfeld, Andrew J.

Volltext

Pipeline to Military Orthopaedic Leadership: 20 Years of Race and Gender Diversity Trends Within Military Orthopaedic Surgery Fellowship Training von Fisher, Miles W.A., Askew, Morgan, Baird, Michael, Ozdemir, Sevil, Williams, Shaun, Ramirez, Valentina, Kilcoyne, Kelly, Dingle, Marvin

Volltext

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial von Preiss, David, Dr, Lloyd, Suzanne M, MSc, Ford, Ian, Prof, McMurray, John J, Prof, Holman, Rury R, Prof, Welsh, Paul, PhD, Fisher, Miles, Prof, Packard, Chris J, Prof, Sattar, Naveed, Prof

Volltext

ADVANCE-ON: further support for intensive glucose control in type 2 diabetes von Fisher, Miles

Volltext

Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis von Fisher, Miles, Prof, Petrie, Mark C, MD, Ambery, Philip D, FRCP, Donaldson, Jill, PhD, McMurray, John J V, Prof, Ye, June

Volltext

Series: Cardiovascular outcome trials for diabetes drugs: Cardiovascular outcome trials with GLP-1 receptor agonists from exenatide and EXSCEL von Fisher, Miles

Volltext

Diabetes Drug Notes von Fisher, Miles, McKay, Gerard A, Llano, Andrea

Volltext

Increasing Physical Activity in People With Type 2 Diabetes von KIRK, Alison, MUTRIE, Nanette, MACINTYRE, Paul, FISHER, Miles

Volltext

Series: Cardiovascular outcome trials for diabetes drugs. Linagliptin, CARMELINA and CAROLINA von Fisher, Miles

Volltext

Cardiovascular disease and cardiovascular outcomes in COVID‐19 von Fisher, Miles

Volltext

Clinical relevance of recent outcome trials with antidiabetic drugs von Fisher, Miles

Volltext

Series: Cardiovascular outcome trials for diabetes drugs Canagliflozin and the CANVAS Program, dapagliflozin and DECLARE-TIMI 58, ertugliflozin and VERTIS CV von Fisher, Miles

Volltext

Series: Cardiovascular outcome trials for diabetes drugs Semaglutide and SUSTAIN-6 von Fisher, Miles

Volltext

Series: Cardiovascular outcome trials for diabetes drugs Degludec and DEVOTE von Fisher, Miles

Volltext

Series: Cardiovascular outcome trials for diabetes drugs Liraglutide and LEADER von Fisher, Miles

Volltext

Series: Cardiovascular outcome trials for diabetes drugs Empagliflozin and EMPA-REG OUTCOME von Fisher, Miles

Volltext